Cryo-Cell CEO Mercedes Walton Invites Women to Share Their Ideas on Self-Care and the Power of Stem Cells
30 Dicembre 2009 - 2:30PM
PR Newswire (US)
Free C'elle collection and 20 year storage to be awarded to one
video entrant through its 'Resolution Revolution' New Year's
promotion OLDSMAR, Fla., Dec. 30 /PRNewswire-FirstCall/ --
Cryo-Cell International, Inc. a global leader in stem cell
innovation, resolves to help women inspire and empower each other
to take charge of their health in the New Year, and to spark
conversations about the promise of stem cells. The company will be
accepting video entries for its "Resolution Revolution" contest
through January 31, 2010, and details on the event can be found at
http://www.celle.com/resolution. "This time of year, we often make
New Year's resolutions to take better care of ourselves, but the
dawn of a new decade is particularly poignant as we look ahead with
hope and inspiration at the steps we can take," said Mercedes
Walton, CEO of Cryo-Cell International. "Never in history have we
experienced a time of such rapid advances with stem cells,
including the use of stem cells from menstrual blood and how they
may help women protect their health," she added. "Because women
often look to each other for information and inspiration, we're
looking to empower them to spread the word through video about what
the power of stem cells means to them." The C'elle service is the
first and only one of its kind, empowering women to collect and
cryopreserve stem cells from their menstrual flow. Stem cells from
menstrual blood are proven to be a rich source of stem cells which
proliferate rapidly and have the ability to become many different
types of cells such as cardiac, neural, bone, fat and cartilage.
These stem cells are a potential source for promising regenerative
therapies to treat stroke, cardiac, diabetes, breast cancer, spinal
cord injury, chronic wounds, Alzheimer's and other debilitating
diseases. Since launching its proprietary service, the company
continues to expand research and development initiatives worldwide
in order to accelerate the potential diagnostic and therapeutic
benefits of these unique stem cells. Cryo-Cell partnered with the
National Institutes of Health (NIH) Clinical Center, where research
is underway to better understand the C'elle stem cells and their
potential benefit for the treatment of breast cancer. It also has
entered research and licensing agreements with several other
organizations to identify potential future diagnostic and
therapeutic uses for endometriosis and stress urinary incontinence
in women and regenerative medicine specific to wound healing. In
2009, the service was licensed in China, Thailand and Brazil. For
more information, or to schedule an interview with Cryo-Cell
International executives, please contact Monica Kozak at (203)
545-1055; . About C'elle The C'elle(SM) service was introduced in
November 2007 as the first and only service that empowers women to
collect and cryopreserve menstrual flow containing undifferentiated
adult stem cells for future utilization by the donor or possibly
their first-degree relatives in a manner similar to umbilical cord
blood stem cells. For more information, visit
http://www.celle.com/. About Cryo-Cell International, Inc.
(OTC:CCEL.OB) (BULLETIN BOARD: CCEL.OB) Based in Oldsmar, Florida,
with nearly 200,000 clients worldwide, Cryo-Cell is a global leader
in stem cell innovation. ISO 9001:2000 certified and accredited by
the AABB, Cryo-Cell operates in a state-of-the-art Good
Manufacturing Practice and Good Tissue Practice
(cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded
company. OTC Bulletin Board Symbol: CCEL. For more information,
please call 1-800-STOR-CELL (1-800-786-7235) or visit
http://www.cryo-cell.com/. DATASOURCE: Cryo-Cell International,
Inc. CONTACT: Monica Kozak, +1-203-545-1055, Web Site:
http://www.cryo-cell.com/
Copyright